GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **3926 - 3950** of **4050** in total

« First

‹ Prev

…

154

155

156

157

158

159

160

161

162

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G00054MO	91
IgM	Patient 3	4	mild	G00054MO	81
IgA	Patient 4	12	mild	G00054MO	427
IgG	Patient 4	12	mild	G00054MO	85
IgM	Patient 4	12	mild	G00054MO	137
IgA	Patient 1	10	moderate	G00053MO	329
IgA	Patient 1	22	moderate	G00053MO	318
IgA	Patient 1	6	moderate	G00053MO	203
IgG	Patient 1	10	moderate	G00053MO	23
IgG	Patient 1	22	moderate	G00053MO	22
IgG	Patient 1	6	moderate	G00053MO	26
IgM	Patient 1	10	moderate	G00053MO	32
IgM	Patient 1	22	moderate	G00053MO	38
IgM	Patient 1	6	moderate	G00053MO	47
IgA	Patient 2	15	mild	G00053MO	268
IgA	Patient 2	24	mild	G00053MO	314
IgG	Patient 2	15	mild	G00053MO	30
IgG	Patient 2	24	mild	G00053MO	23
IgM	Patient 2	15	mild	G00053MO	51
IgM	Patient 2	24	mild	G00053MO	46
IgA	Patient 2	3	mild	G00053MO	282
IgG	Patient 2	3	mild	G00053MO	24
IgM	Patient 2	3	mild	G00053MO	40
IgA	Patient 3	-180	mild	G00053MO	255
IgA	Patient 3	11	mild	G00053MO	381